The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.1097968
Abstract: COPYRIGHT © 2022 Forzano, Mone, Varzideh, Jankauskas, Kansakar, De Luca and Santulli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in… read more here.
Keywords: aldosterone synthase; baxdrostat significantly; selective aldosterone; inhibitor baxdrostat ... See more keywords